Citations 1
Update on a Phase 1/2 First-in-Human Study of the Menin-KMT2A (MLL) Inhibitor Ziftomenib (KO-539) in Patients with Relapsed or Refractory Acute Myeloid Leukemia
Fathi, Amir T. , Issa, Ghayas C., Altman, Jessica K. , Montesinos, Pau , Patnaik, Mrinal M. , Foran, James M. , Baer, Maria R. , Schiller, Gary J. , Walter, Roland B. , Kremyanskaya, Marina , Pettit, Kristen , Tomkinson, Blake, Tabachri, Marilyn, Leoni, Mollie , Dale, Stephen , Montesinos, Pau , Walter, Roland B , Pettit, Kristen , Erba, Harry Paul , Issa, Ghayas , Botton, Stéphane de , Strickland, Stephen Anthony , Wang, Eunice S.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 153-156
